Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Hepatology

Why LAL-D is Often Misdiagnosed

At a Glance

Lysosomal Acid Lipase Deficiency (LAL-D) is a rare genetic disease often misdiagnosed as fatty liver (NAFLD) or high cholesterol. It is caused by a LIPA gene mutation that leads to dangerous fat buildup in the liver. A simple Dried Blood Spot (DBS) test checking LAL enzyme activity provides the definitive diagnosis.

Lysosomal Acid Lipase Deficiency (LAL-D) is often called a “great mimicker.” Because its symptoms look identical to more common diseases like high cholesterol or fatty liver, it is frequently missed by doctors who may not be looking for a rare genetic cause [1][2].

The Biology: A “Lipid Logjam”

To understand why LAL-D affects the body the way it does, we have to look at the LIPA gene. This gene provides the instructions for making an enzyme called lysosomal acid lipase (LAL) [3].

Think of the lysosome as the “recycling center” of your cells. Its job is to take in fats—specifically cholesteryl esters and triglycerides—and break them down into smaller pieces the body can use [3][4].

  • In LAL-D: Because of a mutation in the LIPA gene, the LAL enzyme is either missing or doesn’t work correctly [1].
  • The Result: Fats enter the recycling center but cannot be broken down. They pile up inside the cells, creating a “lipid logjam” [1].
  • The Damage: This buildup primarily happens in the liver and in specialized immune cells called macrophages [1][5]. As these cells swell with fat, they trigger inflammation, cause the liver to enlarge, and eventually lead to scarring (fibrosis) [3][6].

Why It Gets Missed (The Look-Alikes)

Because the symptoms are so similar to common conditions, LAL-D is often hidden behind other diagnoses.

1. Familial Hypercholesterolemia (FH)

Both conditions cause dangerously high LDL (“bad” cholesterol). However, while FH is mainly a blood lipid problem, LAL-D also causes an enlarged liver and elevated liver enzymes [1][2].

2. NAFLD and NASH (Fatty Liver Disease)

LAL-D is often mistaken for common non-alcoholic fatty liver disease (NAFLD) because both show fat on liver imaging [7]. A key clue for LAL-D is if the patient is not obese or if the liver fat does not improve even with a strict diet and weight loss [1][8].

3. HLH (In Infants)

In its most severe form, LAL-D can look like Hemophagocytic Lymphohistiocytosis (HLH), a life-threatening immune condition [9]. Both cause a massive spleen, low blood counts, and high fevers [10]. Doctors must check for adrenal calcification or perform an enzyme test to tell them apart [9][11].

Distinguishing LAL-D from the Look-Alikes

Feature LAL-D NAFLD / NASH Familial Hypercholesterolemia
Primary Cause Genetic (LIPA gene) Diet, Obesity, Insulin Resistance Genetic (LDL Receptor, etc.)
Liver Fat Always present (Microvesicular) Often present (Macrovesicular) Usually absent
LDL Cholesterol Very High Usually High Extremely High
ALT / AST Enzymes Usually Elevated Often Elevated Usually Normal
Spleen Size Enlarged Usually Normal Usually Normal
Key Diagnostic Test LAL Enzyme Activity (DBS) Imaging / Biopsy Genetic Testing / Lipid Panel

The Power of the “Dried Blood Spot”

The most important tool for a correct diagnosis is the Dried Blood Spot (DBS) test [12]. This simple blood test measures the actual activity of the LAL enzyme [13]. While other tests (like a liver biopsy) can show signs of the disease, the DBS test provides the definitive proof by showing that the LAL enzyme is missing or deficient [12][1].

Common questions in this guide

Why is LAL-D often misdiagnosed as fatty liver disease?
LAL-D causes fat to build up in the liver, which looks very similar to common non-alcoholic fatty liver disease (NAFLD) on imaging. A key clue that it might be LAL-D is if the patient is not overweight, or if their liver fat does not improve despite a strict diet and weight loss.
What is the best test to definitively diagnose LAL-D?
The most accurate way to definitively diagnose LAL-D is a Dried Blood Spot (DBS) test. This simple blood test measures the actual activity of the lysosomal acid lipase enzyme to prove whether it is missing or deficient.
How is LAL-D different from familial hypercholesterolemia (FH)?
While both conditions cause dangerously high LDL or bad cholesterol, LAL-D also typically causes an enlarged liver and elevated liver enzymes. Familial hypercholesterolemia is mainly a blood lipid problem without the liver swelling and damage seen in LAL-D.
What causes Lysosomal Acid Lipase Deficiency?
LAL-D is caused by an inherited mutation in the LIPA gene. This mutation prevents the body from making a working LAL enzyme, meaning the cells can no longer break down certain fats, causing a dangerous buildup in the body.
Why is LAL-D sometimes mistaken for HLH in infants?
In infants, severe LAL-D can look like an immune condition called HLH because both cause a massive spleen, low blood counts, and high fevers. Doctors can tell them apart by checking for calcification in the adrenal glands or by running a LAL enzyme test.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since LAL-D mimics other conditions, what specific test (like a Dried Blood Spot) was used to confirm my diagnosis?
  2. 2.If I was previously diagnosed with NAFLD or high cholesterol, why did those treatments not work, and how does LAL-D explain that?
  3. 3.In an infant's case, how was HLH ruled out, and were there findings like adrenal calcification?
  4. 4.What does 'microvesicular steatosis' mean in the context of my liver biopsy or imaging results?
  5. 5.Should my siblings or other family members be screened for LAL enzyme activity?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.

    Reiner Ž, Guardamagna O, Nair D, et al.

    Atherosclerosis 2014; (235(1)):21-30.

    PMID: 24792990
  2. 2

    Distinguishing Lysosomal Acid Lipase Deficiency From Familial Hypercholesterolemia.

    Sheth S, Toth PP, Baum SJ, Aggarwal M

    JACC. Case reports 2023; (24()):102023 doi:10.1016/j.jaccas.2023.102023.

    PMID: 37869222
  3. 3

    A rare cause of hepatomegaly in the childhood: Lysosomal acid lipase deficiency.

    Haznedar P, Kuloğlu Z, Kansu A, Eminoğlu FT

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2018; (29(4)):518-519 doi:10.5152/tjg.2018.17492.

    PMID: 30249571
  4. 4

    Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group.

    Kohli R, Ratziu V, Fiel MI, et al.

    Molecular genetics and metabolism 2020; (129(2)):59-66 doi:10.1016/j.ymgme.2019.11.004.

    PMID: 31767214
  5. 5

    Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.

    Baratta F, Pastori D, Tozzi G, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2019; (39(12)):2301-2308 doi:10.1111/liv.14206.

    PMID: 31392821
  6. 6

    Pedigree Analysis of Nonclassical Cholesteryl Ester Storage Disease with Dominant Inheritance in a LIPA I378T Heterozygous Carrier.

    Zhang JH, Lin AP, Zhang L, et al.

    Digestive diseases and sciences 2024; (69(6)):2109-2122 doi:10.1007/s10620-024-08395-9.

    PMID: 38564148
  7. 7

    Lysosomal Acid Lipase Deficiency: A Report of Two Cases and a Review of the Literature.

    Nedelcu C, Dijmarescu I, Patrascoiu M, et al.

    Cureus 2024; (16(11)):e73299 doi:10.7759/cureus.73299.

    PMID: 39650963
  8. 8

    Lysosomal Acid Lipase Deficiency Unmasked in Two Children With Nonalcoholic Fatty Liver Disease.

    Himes RW, Barlow SE, Bove K, et al.

    Pediatrics 2016; (138(4)).

    PMID: 27624512
  9. 9

    Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update.

    Bay L, Canero Velasco C, Ciocca M, et al.

    Archivos argentinos de pediatria 2017; (115(3)):287-293 doi:10.5546/aap.2017.eng.287.

    PMID: 28504497
  10. 10

    Hemophagocytic Lymphohistiocytosis: A Rare Complication of an Ultrarare Lysosomal Storage Disease.

    Chabchoub I, Boudabbous H, Maaloul I, et al.

    Journal of pediatric hematology/oncology 2020; (42(4)):310-312 doi:10.1097/MPH.0000000000001552.

    PMID: 31318819
  11. 11

    Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa.

    Santos Silva E, Klaudel-Dreszler M, Bakuła A, et al.

    Clinics and research in hepatology and gastroenterology 2018; (42(5)):e77-e82 doi:10.1016/j.clinre.2018.03.012.

    PMID: 29705274
  12. 12

    Lysosomal acid lipase deficiency - early diagnosis is the key.

    Strebinger G, Müller E, Feldman A, Aigner E

    Hepatic medicine : evidence and research 2019; (11()):79-88 doi:10.2147/HMER.S201630.

    PMID: 31213932
  13. 13

    Stratification of patients with lysosomal acid lipase deficiency by enzyme activity in dried blood spots.

    Hong X, Chen Y, Barr M, Gelb MH

    Molecular genetics and metabolism reports 2022; (33()):100935 doi:10.1016/j.ymgmr.2022.100935.

    PMID: 36393897

This page explains LAL-D diagnostic challenges for educational purposes only. Always consult your hepatologist, pediatrician, or geneticist for proper evaluation, testing, and medical advice.

Get notified when new evidence is published on Lysosomal acid lipase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.